At 79 years old, Tom Rauscher works out every day, sets big goals like 1 million V-ups, and still enjoys the occasional ...
LYL273 has demonstrated a 67% overall response rate, an 83% disease control rate, and a manageable safety profile at the ...
We’ve moved on,” said Chester Mayor Stefan Roots. “Go Away. We’re not entertaining another bad deal that harms the people who ...
Lunai Bioworks (NASDAQ: LNAI), an AI-powered drug discovery and biodefense company, has announced a major scientific ...
Preclinical data support best-in-class potential of masked T cell engager programs and platform utilizing Xilio’s ATACR and SEECR formats, ...
FOSTER CITY, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage oncology company, today reported financial results for ...
Detailed price information for Candel Therapeutics Inc (CADL-Q) from The Globe and Mail including charting and trades.
Hu, X.Y. (2025) The Opportunities and Challenges of Declining Birthrates for Small-Class Science Teaching in Secondary Schools. Open Access Library Journal, 12, 1-8. doi: 10.4236/oalib.1114434 .
As per SNS Insider Research, The DNA Manufacturing Market growth is driven by plasmid DNA demand, biopharma innovation, and advancements in DNA-based vaccine production.Austin, Nov. 07, 2025 (GLOBE ...
A $16 million planned gift from a longtime University of Maryland faculty member will empower researchers and students in the Department of Cell Biology and Molecular Genetics to conduct research on ...
Analysis identifies regions in the breast where higher radiation dose is associated with pain, edema, atrophy, and induration ...
SALT LAKE CITY, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results